Distinct Metabolomic Signatures in Preclinical and Obstructive Hypertrophic Cardiomyopathy.

MLA

Schuldt, Maike, et al. “Distinct Metabolomic Signatures in Preclinical and Obstructive Hypertrophic Cardiomyopathy.” Cells (2073-4409), vol. 10, no. 11, Nov. 2021, p. 2950. EBSCOhost, https://doi.org/10.3390/cells10112950.

APA

Schuldt, M., van Driel, B., Algül, S., Parbhudayal, R. Y., Barge-Schaapveld, D. Q. C. M., Güçlü, A., Jansen, M., Michels, M., Baas, A. F., van de Wiel, M. A., Nieuwdorp, M., Levin, E., Germans, T., Jans, J. J. M., & van der Velden, J. (2021). Distinct Metabolomic Signatures in Preclinical and Obstructive Hypertrophic Cardiomyopathy. Cells (2073-4409), 10(11), 2950. https://doi.org/10.3390/cells10112950

Chicago

Schuldt, Maike, Beau van Driel, Sila Algül, Rahana Y. Parbhudayal, Daniela Q. C. M. Barge-Schaapveld, Ahmet Güçlü, Mark Jansen, et al. 2021. “Distinct Metabolomic Signatures in Preclinical and Obstructive Hypertrophic Cardiomyopathy.” Cells (2073-4409) 10 (11): 2950. doi:10.3390/cells10112950.